Salarius Pharmaceuticals (SLRX) Stock Chart & Stock Price History $6.66 -0.27 (-3.93%) As of 02:56 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock Salarius Pharmaceuticals Stock Price Performance The Salarius Pharmaceuticals (SLRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 76.65%, with a year-to-date return of -75.89%. In the past month, the stock has decreased 27.84%, reflecting recent market activity. As of the latest close, Salarius Pharmaceuticals traded at $6.93 with a market cap of $984 thousand and volume of 42,338 shares. Five years ago, the stock traded at a split-adjusted price of $3,120.00, representing a 99.79% decrease over that period. At the time, it had a market cap of $13.72 million and a volume of 4,453 shares. Receive SLRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Salarius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-8.30%1 Month Performance-27.84%3 Month Performance-46.58%Year-To-Date Performance-75.89%1 Year Performance-76.65%5 Year Performance-99.79% SLRX Stock Chart for Monday, August, 18, 2025 SLRX Chart by TradingView Salarius Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/15/2025$6.79$6.93+2.01%$6.93$6.4542,338 shs$984,000.0008/14/2025$7.26$6.79-6.43%$7.20$6.7538,530 shs$964,000.0008/13/2025$8.25$7.26-12.04%$7.92$6.9454,687 shs$1.03 million08/12/2025$8.54$8.25-3.41%$8.85$7.9525,528 shs$1.17 million08/11/2025$7.50$8.54+13.88%$8.69$7.7979,648 shs$1.21 million08/08/2025$8.34$7.50-10.07%$8.40$6.8748,486 shs$1.07 million08/07/2025$7.91$8.34+5.50%$8.64$7.8027,124 shs$1.18 million08/06/2025$8.70$7.91-9.14%$8.78$7.8048,734 shs$1.12 million08/05/2025$9.15$8.70-4.92%$9.45$8.5572,302 shs$1.24 million08/04/2025$9.45$9.15-3.17%$10.05$8.8539,615 shs$1.30 million Get the Latest News and Ratings for SLRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Salarius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 08/01/2025$8.99$9.45+5.12%$10.50$8.81269,531 shs$1.34 million07/31/2025$11.74$8.99-23.44%$10.95$8.90143,309 shs$1.28 million07/30/2025$14.99$11.74-21.69%$13.80$10.88364,173 shs$1.67 million07/29/2025$11.12$14.99+34.88%$34.65$14.556.55 million shs$2.13 million07/28/2025$11.25$11.12-1.19%$12.00$10.8010,544 shs$1.58 million07/25/2025$11.27$11.25-0.17%$11.70$10.6816,778 shs$1.60 million07/24/2025$10.50$11.27+7.33%$11.55$10.2224,877 shs$1.60 million07/23/2025$10.65$10.50-1.44%$10.88$10.206,529 shs$1.49 million07/22/2025$10.89$10.65-2.18%$11.25$10.088,880 shs$1.51 million07/21/2025$9.22$10.89+18.09%$11.25$9.3017,814 shs$1.55 million07/18/2025$9.20$9.22+0.26%$9.73$9.158,026 shs$1.31 million07/17/2025$9.45$9.20-2.68%$9.90$8.9716,138 shs$1.31 million Related Companies ENSC Stock Chart VIVS Stock Chart CPHI Stock Chart BCTX Stock Chart INDP Stock Chart TCRT Stock Chart SLXN Stock Chart GLTO Stock Chart INM Stock Chart CMND Stock Chart Receive SLRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Salarius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SLRX) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | Sponsored"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Salarius Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Salarius Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access